Starling Oncology, Inc. SEC filings STLNW

Starling Oncology, Inc. has 544 filings in SEC EDGAR's recent list, going back to Jan 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Starling Oncology, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 17, 2026
DEFA14A Additional proxy material Mar 27, 2025 —
DEF 14A Proxy statement Mar 27, 2025 May 7, 2025
PRE 14A Preliminary proxy statement Mar 14, 2025 May 7, 2025
DEFA14A Additional proxy material May 2, 2024 —
DEF 14A Proxy statement May 2, 2024 Jun 13, 2024
PRE 14A Preliminary proxy statement Apr 22, 2024 Jun 13, 2024
DEFA14A Additional proxy material Jun 14, 2023 —
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 15, 2023
DEFA14A Additional proxy material Jun 3, 2022 —
DEF 14A Proxy statement Jun 3, 2022 Jul 14, 2022

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cerritos, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1799191
Former names
Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.